OHDSI Global Symposium

The OHDSI Global Symposium is set to take place at the Hyatt Regency in New Brunswick, United States. This prestigious event will focus on the latest advancements in health data science and the use of real-world evidence in healthcare. It promises a rich agenda featuring various topics, including the semiautomatic mapping of national drug terminologies to standardized OMOP drug concepts and an analysis of changes in drug utilization patterns amidst reported shortages in Europe and North America. Notable presentations will cover the secular trends in the use of valproate-containing medicines among women of childbearing age in Europe, showcasing the valuable insights generated from multinational studies.Esteemed contributors to the symposium include Hua Xu, an expert in clinical natural language processing (NLP), who will share his experience and the impact of NLP on the OHDSI mission. His lab's development of the CLAMP toolkit highlights the application of NLP in generating real-world evidence. Additionally, the symposium will feature a spotlight on recent publications, including a study that examines the association between DPP4 inhibitors, metformin, and cancer risk in patients with Type 2 diabetes. Attendees can also look forward to tutorials from past Global and US Symposia, providing further educational resources. With an immersive agenda, the OHDSI Global Symposium aims to advance understanding and collaboration in health data research, ensuring that participants gain practical skills to work with real-world health data.